Business Wire

Tula Technology to Demonstrate Dynamic Motor Drive® (DMD) at Vienna Motor Symposium

Share

Tula Technology, Inc., a leader in propulsion efficiency, will put its Dynamic Motor Drive® (DMD) technology into action at the 45th International Vienna Motor Symposium on April 24-26 in Vienna, Austria. Tula has retrofitted a Tesla Model 3 with an externally excited synchronous motor (EESM) running DMD software, and this innovative strategy will be demonstrated at the conference.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416986692/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tula has retrofitted a Tesla Model 3 with an externally excited synchronous motor (EESM) running Dynamic Motor Drive® software. This innovative technology will be demonstrated at the 45th International Vienna Motor Symposium on April 24-26 in Vienna, Austria.(Photo: Business Wire)

Tula developed DMD to improve electric drive efficiency with a software-only solution. With an optimized pulsing strategy, DMD reduces energy consumption while having no perceptible impact on vehicle noise and vibration. Depending upon application, DMD with EESM can reduce energy consumption by up to 3%. This efficiency improvement can be directly translated into reduced battery size and cost, or alternatively, increased range.

Putting DMD to the test in a Tesla Model 3

Improved efficiency coupled with imperceptible operation is not only possible, Tula has now proven the feasibility of DMD in two vehicles with fundamentally different electric propulsion systems. In its latest effort, Tula retrofitted the permanent magnet synchronous motor (PMSM) in a Tesla Model 3 with a wound rotor to create an EESM. Tula then incorporated its proprietary DMD control logic to reduce energy consumption and improve overall system efficiency.

In 2022, Tula’s initial DMD application utilized a Chevrolet Bolt with an unmodified PMSM drive unit. Testing showed that DMD meaningfully improved the Bolt’s energy consumption while maintaining drive quality, demonstrating the value of DMD in PMSM applications.

DMD’s role in tomorrow’s powertrain

Improving the efficiency and lowering the cost of electric vehicle powertrains is one of the most critical challenges facing the automotive world today. Further, when developing powertrains for the future, manufacturers will increasingly seek to reduce their dependence on problematic rare earth elements. The combination of EESM and DMD supports that goal while being highly competitive in terms of both efficiency and cost. Although many motors will still be PMSM, Tula’s DMD technology also provides a high-value efficiency gain there. Overall, DMD is a scalable, adaptable, cost competitive and sustainable solution that makes electrified propulsion systems more efficient, accelerating the transition to an electrified future.

Members of Tula’s DMD development team will present a paper on their DMD findings at the Vienna Motor Symposium.

About Tula Technology, Inc.

Silicon Valley-based Tula Technology provides innovative award-winning software controls to optimize propulsion efficiency and emissions across the mobility spectrum, including electric, hybrid, gasoline, diesel, and alternative fuel vehicles. Tula’s culture of innovation has resulted in breakthrough technologies and a robust global patent portfolio of more than 400 patents issued and pending. Tula Technology is a privately held company backed by Sequoia Capital, Sigma Partners, Khosla Ventures, GM Ventures, BorgWarner and Franklin Templeton. More information is available at www.tulatech.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media: Financial Profiles
Tricia Ross
tross@finprofiles.com
310-622-8226

Investors: Financial Profiles
Julie Kegley
jkegley@finprofiles.com
310-622-8246

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

WEF Special Meeting Concludes in Riyadh With World Leaders Calling for Clear, Irreversible Path to Peace and Prosperity as Top Global Priority30.4.2024 00:02:00 EEST | Press release

Riyadh hosted more than 1,000 global leaders for the two-day World Economic Forum (WEF) Special Meeting in Riyadh, where leading political, economics, energy and technology figures called for clear pathways to stability, prosperity and inclusive growth opportunities in the face of rising cross-border challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429767765/en/ Saudi Minister of Economy and Planning His Excellency Faisal Alibrahim announces Saudi Arabia will join the AI Governance Alliance to co-launch the ‘Inclusive AI Initiative for Growth and Development’ (Photo: AETOSWire) The more than 1,000 participants in for the WEF Special Meeting on Global Collaboration, Growth and Energy for Development made it the highest-ever number of registrations for a WEF event hosted outside of its Annual Meeting venue in Davos Klosters, Switzerland. The Special Meeting set the stage for the launch of several initiatives in th

CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology30.4.2024 00:00:00 EEST | Press release

Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO AND GLYCAN BIOLOGY GanNA founders include Carolyn Bertozzi, Ph.D., Richard D. Cummings, Ph.D., Ryan A. Flynn, M.D., Ph.D., and Namita Bisaria, Ph.D., M.B.A. Additional investment strengthens ReNAgade’s delivery platform with unique conjugation platform based on novel glycobiology ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to unlock the potential of glycobiology through support for ongoing research at GanNA Bio, and an integration of the key founders of GanNA Bio into the ReNAgade ecosystem. GanNA Bio was formed in 2021 and invested in by ReNAgade to harness novel glycobiology to enable extra-hepatic RNA delivery based on pioneering research licensed from Stanford University, Boston Children’s Hospital, and Beth Is

Sun Nuclear Announces Landmark Update to Further Advance Radiation Therapy Workflows29.4.2024 23:30:00 EEST | Press release

Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK® software for comprehensive Quality Management in radiation therapy. The SunCHECK software is used globally by radiation therapy departments to manage delivery system oversight and patient-specific treatment quality --- all in one platform. SunCHECK Version 5.0 introduces a broad range of features and user-driven enhancements that optimize workflows and prioritize patient safety. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429991805/en/ Sun Nuclear, a Mirion Medical company, announced the upcoming version 5.0 release of its SunCHECK® software for comprehensive Quality Management in radiation therapy. SunCHECK v5.0 addresses clinical workflow challenges with new treatment plan assessment capabilities, enhanced TPS/OIS integration, expanded QA device control, and worklist-based UI. (Graphic: Business Wire) The Connecte

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company29.4.2024 23:05:00 EEST | Press release

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments. “Endomag’s suite of solutions complements our existing breast surgery portfolio and will provide surgeons and radiologists with an expanded range of options to meet the individual needs of more patients undergoing critical breast cancer procedures,” said Erik Anderson, President of Breast and Skeletal Health Solutions at Hologic. “With a global footprint and a similar commitment to women’s health, we are excited about the potential of welcoming the Endomag team and our future opportunities together to increase access to these technologies and better serve patients across the breast health continuum of care.” Endomag, which is based in Cambridge, United Kingdom, deve

PsiQuantum to Build World’s First Utility-Scale, Fault-Tolerant Quantum Computer in Australia29.4.2024 23:00:00 EEST | Press release

PsiQuantum today announced it will build the world’s first utility-scale quantum computer at a strategically located site near Brisbane Airport in Brisbane, Australia. The Australian Commonwealth and Queensland Governments will invest $940M AUD ($620M USD) into PsiQuantum through a financial package, comprised of equity, grants, and loans. PsiQuantum is on an aggressive plan to have the site operational by the end of 2027. A fault-tolerant quantum computer will be able to solve commercially useful problems across industries built upon chemistry, math, and physics; thereby transforming critical industries – including renewable energy, minerals and metals, healthcare and transportation – that will propel the global economy for decades to come. The quantum computing industry has long faced complicated scaling challenges in building a quantum computer with enough physical qubits to enable error-correction, making it capable of delivering on quantum computing’s promise. PsiQuantum has scale

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye